Skip to content
TrialMatch
Sign up
Recruiting

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Create a profile to match View the full record on ClinicalTrials.gov

About this study

The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model aims to accurately diagnose mutiple pulmonary diseases. The primary objectives it strives to accomplish are: 1. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose several common pulmonary diseases. 2. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose more pulmonary diseases.

Condition
Lung Cancer, Lung Infection, COPD, Bronchitis, Pulmonary Fibrosis, Pulmonary Embolism, Pulmonary Arterial Hypertension, Pulmonary Tuberculosis, Pulmonary Abscess, Emphysema, Lung Injury, Cystic Fibrosis of the Lung, Bronchial Asthma, Bronchiectasis, Interstitial Lung Disease, Preserved Ratio Impaired Spirometry
Tested
Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system
Sponsor
ChromX Health

Who can join

Age
18 to 100 years
Sex
All sexes
Healthy volunteers
Accepted

Inclusion 7

  • Minimum age: 18 years
  • Maximum age: 100 years
  • Study condition: Lung Cancer, Lung Infection, COPD, Bronchitis, Pulmonary Fibrosis, Pulmonary Embolism, Pulmonary Arterial Hypertension, Pulmonary Tuberculosis, Pulmonary Abscess, Emphysema, Lung Injury, Cystic Fibrosis of the Lung, Bronchial Asthma, Bronchiectasis, Interstitial Lung Disease, Preserved Ratio Impaired Spirometry
  • Males or females, age must be 18 years old or above.
  • Patients must meet the CT imaging diagnostic criteria for different lung diseases, and patients must be able to provide electronic versions of CT image data.
  • Patients must have a clear clinical diagnosis.
  • All participants must sign a written informed consent form.

Exclusion 6

  • Pregnant women.
  • Individuals with a history of cancer other than lung disease.
  • Individuals who have undergone organ transplants or non-autologous (allogeneic) bone marrow or stem cell transplants.
  • Individuals with other severe organic diseases or mental illnesses.
  • Individuals with metabolic diseases such as diabetes, hyperlipidemia, etc.
  • Any other condition that researchers deem unsuitable for participation in this clinical trial.

Where

1 site, 1 recruiting

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.